Evidence map›Paper›PMID 41942761›Full record

ArticleCommunications biology2026

Hypertonicity-induced RNF183 targets NKCC1 to protect kidney collecting duct cells but induces apoptosis in colon cells.

Takumi Okamoto, Yuki Higashi, Masaaki Takemoto, Koji Matsuhisa, Shinya Sato, Atsushi Saito, Issei Omura, Yasunao Kamikawa, Kazunori Imaizumi, Masayuki Kaneko

Abstract read
In one paragraph

Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Takumi Okamoto *Department of Pharmacology and Therapeutic Innovation, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.ORCID http://orcid.org/0009-0003-7003-1312
Yuki Higashi *Department of Pharmacology and Therapeutic Innovation, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Masaaki Takemoto *Department of Pharmacology and Therapeutic Innovation, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Koji MatsuhisaDepartment of Pharmacology and Therapeutic Innovation, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. matsuhisa@nagasaki-u.ac.jp.ORCID http://orcid.org/0000-0003-0707-9025
Shinya SatoDepartment of Pharmacology and Therapeutic Innovation, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Atsushi SaitoDepartment of Frontier Science and Interdisciplinary Research, Faculty of Medicine, Kanazawa University, Kanazawa, Ishikawa, Japan.
Issei OmuraDepartment of Frontier Science and Interdisciplinary Research, Faculty of Medicine, Kanazawa University, Kanazawa, Ishikawa, Japan.ORCID http://orcid.org/0000-0003-4504-814X
Yasunao KamikawaDepartment of Biochemistry, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.
Kazunori ImaizumiThe Osaka Medical Research Foundation for Intractable Diseases, Osaka, Japan.
Masayuki KanekoDepartment of Pharmacology and Therapeutic Innovation, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. m-kaneko@nagasaki-u.ac.jp.ORCID http://orcid.org/0000-0002-0477-0171

Funding

MEXT | Japan Society for the Promotion of Science (JSPS) 21K06595MEXT | Japan Society for the Promotion of Science (JSPS) 22KJ2499MEXT | Japan Society for the Promotion of Science (JSPS) 23K17413MEXT | Japan Society for the Promotion of Science (JSPS) 25K02426
6 · The paper itself

Abstract

RING-finger protein 183 (RNF183) is a ubiquitin ligase specifically expressed in the kidney and especially in collecting ducts that are constantly exposed to hypertonic stress. The expression of RNF183 in the colon is low but is upregulated in patients with inflammatory bowel disease (IBD) and patients with colorectal cancer. However, the function and relationship of RNF183 with these diseases remain unclear. Here, we identify the Na-K-2Cl co-transporter NKCC1 as a substrate of RNF183. RNF183 promotes K63-linked ubiquitination of NKCC1, leading to its lysosomal degradation, which is enhanced under hypertonic conditions. Dysregulation of RNF183 expression increases hypertonic-induced cell death in Rnf183-knockout mIMCD-3 cells and RNF183-overexpressing Caco-2 cells, accompanied by an increase in cleaved caspase-3. Under isotonic and hypertonic conditions, intracellular Na

Indexed as

ApoptosisColonKidney Tubules, CollectingSolute Carrier Family 12, Member 2Ubiquitin-Protein LigasesAnimalsCaco-2 CellsHumansMiceUbiquitinationSLC12A2 protein, humanSolute Carrier Family 12, Member 2Ubiquitin-Protein Ligases

Identifiers

PMID41942761
PMCPMC13230821

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.